Clinical trials
Completed Phase 1/2 Small Cell Lung Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2003 | 1 |
| 2006 | 2 |
| 2007 | 4 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 7 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 6 |
| 2021 | 3 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 49 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 6 |
| Amgen | 2 |
| G1 Therapeutics, Inc. | 2 |
| Incyte Biosciences International Sàrl | 2 |
| TransThera Sciences (Nanjing), Inc. | 2 |
| University of Alabama at Birmingham | 2 |
| AbbVie | 1 |
| AbbVie (prior sponsor, Abbott) | 1 |
| Aeglea Biotherapeutics | 1 |
| Antonio Calles Blanco | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Small Cell Lung Carcinoma | 49 |
| Carcinoma, Non-Small-Cell Lung | 13 |
| Triple Negative Breast Neoplasms | 10 |
| Ovarian Neoplasms | 9 |
| Breast Neoplasms | 6 |
| Stomach Neoplasms | 6 |
| Sarcoma | 5 |
| Uterine Cervical Neoplasms | 5 |
| Endometrial Neoplasms | 4 |
| Esophageal Neoplasms | 4 |
Trials
Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.